HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Daniela Göppner Selected Research

Daniela Göppner Research Topics

Disease

13Melanoma (Melanoma, Malignant)
11/2023 - 01/2011
6Neoplasms (Cancer)
01/2016 - 07/2010
3Neoplasm Metastasis (Metastasis)
11/2023 - 04/2015
3Skin Neoplasms (Skin Cancer)
01/2017 - 01/2016
1Cytokine Release Syndrome
10/2021
1Exanthema (Rash)
01/2021
1Bullous Pemphigoid (Pemphigoid)
01/2020
1Disease Progression
01/2016
1Hepatocellular Carcinoma (Hepatoma)
04/2015
1Cholangitis
04/2015
1Atopic Dermatitis (Atopic Eczema)
03/2013
1Basal Cell Carcinoma (Rodent Ulcer)
01/2011
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
10/2010
1Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous)
07/2010

Drug/Important Bio-Agent (IBA)

3VemurafenibIBA
11/2023 - 09/2014
3pembrolizumabIBA
10/2021 - 01/2016
3IpilimumabIBA
01/2017 - 01/2013
2cobimetinibIBA
11/2023 - 01/2021
2Immune Checkpoint InhibitorsIBA
01/2017 - 01/2016
2NivolumabIBA
01/2016 - 01/2016
2AntibodiesIBA
01/2016 - 01/2016
1encorafenibIBA
10/2021
1binimetinibIBA
10/2021
1Creatine Kinase (Creatine Phosphokinase)IBA
10/2021
1TransferasesIBA
10/2021
1Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA
10/2021
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
01/2021
1Proteins (Proteins, Gene)FDA Link
01/2020
1AutoantibodiesIBA
01/2020
1Indocyanine Green (Cardio-Green)FDA LinkGeneric
02/2017
1Monoclonal AntibodiesIBA
01/2017
1Interferon alpha-2 (Roferon-A)FDA Link
12/2015
1GlobulinsIBA
03/2013
1Omalizumab (Xolair)FDA Link
03/2013
1Cetuximab (Erbitux)FDA Link
10/2010
1denileukin diftitox (Ontak)FDA Link
07/2010

Therapy/Procedure

9Therapeutics
11/2023 - 07/2010
2Aftercare (After-Treatment)
01/2021 - 04/2015
1Drug Tapering
01/2021
1Immunotherapy
01/2017
1Brachytherapy
04/2015
1Radiofrequency Ablation
04/2015
1Radioimmunotherapy
07/2010